Skip to main content
Premium Trial:

Request an Annual Quote

Greg Richard

Interpace Diagnostics has promoted Greg Richard to the position of chief commercial officer. He previously served as senior vice president of commercial operations. Richard has worked in the healthcare business in various positions for more than 25 years, starting in sales at Aetna, and then moving to Genentech as the director of managed care. He also served as vice president of managed care for Quest Diagnostics, vice president of sales for the Northeast division of LabCorp, and worked for several privately held companies focused in various areas including specialty CROs, molecular diagnostics, and anatomic pathology services. 

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.